Cancer medicine prices may drop 70 per cent as government plans trade margin cap

Prices of several anti-cancer medicines may fall by up to 70 per cent as the government moves to cap trade margins at 30 per cent of the Maximum Retail Price (MRP) for non-scheduled anti-cancer drugs, according to official sources.